AbCellera Biologics Inc (ABCL)
2.83
-0.12
(-4.07%)
USD |
NASDAQ |
Nov 26, 16:00
2.825
0.00 (0.00%)
After-Hours: 20:00
AbCellera Biologics Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.0253 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.3736 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
0.3736
Maximum
Dec 2019
0.0222
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.393B |
| Total Liabilities (Quarterly) | 314.73M |
| Shareholders Equity (Quarterly) | 1.078B |
| Current Ratio | 9.336 |